| To ensure delivery directly to your inbox, please add mailshots@itmahal.com to your address book today. |
Vol No.4; Issue 01; Jan 2012 |
|
|
|
|
Global Pharmaceutical Technology is the leading pharma title in Online, digital versions serving the information needs of key executives from the world's leading pharmaceutical companies. This portal covers Pharmaceutical Events, important Issues and Trends, News, Press Releases shaping the future of the pharmaceutical industry across the world. |
|
|
|
Peak Biotech A/S
22 rue Lavoisier
Nanterre, Cedex - 92022
France
 Peak Biotech A/S is company with focus on pilot- and process scale customized chromatography equipment for the Pharmaceutical and Biotech industry. and.etc.,
|
IN THIS ISSUE
|
To publicize your company profile to improve your Pharmaceutical Business by generating High Range leads,
Write Us |
|
DIA/FDA Oligonucleotide-Based Therapeutics 2012
16th to 18th April 2012
 DIA is committed to the broad dissemination of information among our members, with continuously improved ..etc,
Venue :Washington Marriott Metro Center, Washington, DC, USA.
Organization : DIA ;
sector Type : Forum
|
|
To publicizing your Events on Global Pharmaceutical Technology's website and e-newsletter — write to
Mr. Kevin |
|
|
Lonza signs a deal with Immune Pharmaceuticals
— by Basel
Lonza announced today an exclusive contract for the production of Immune Pharmaceutical's human immunoglobulin monoclonal antibody, Bertilimumab, under investigation..etc.,
|
ANC to push for state drugs maker
— by TAMAR KAHN
African National Congress (ANC) has instructed the Cabinet lekgotla ..etc,
|
|
|
New Pharmaceuticals market report from Datamonitor
— by samlenbo
Over the next decade, the fragmented antibacterials market will shift away from a blockbuster-business model, as generic erosion of market leaders and increased competition between new hospital drugs will trigger a decline in sales of branded antibacterials...etc,
|
Drug firms consider delaying PBS listings
— by caoshin
Drug companies are threatening to delay listing their products on the pharmaceutical benefits scheme in protest at changes to how drugs are being selected..etc.,
|
|
|
|
|
Stay Informed . . .
Ask Digital Magazine publicizing
Publicizing your business in GPT's Digital Magazine Write Us
Global Campaign/Online
To Publicize in Website, e-Newsletter
/ e-Mailer or E-Book Write Us (it publish through 158,900 subscribers)
|
Other e-Newsletter Titles
Construction Tools
Education Technology
Healthcare Technology
Automotive Technology
Subscribe Today !
|
|
|
|
|
Mr. Tom Collen
